AU2001259511A1 - Novel anti-infectives - Google Patents
Novel anti-infectivesInfo
- Publication number
- AU2001259511A1 AU2001259511A1 AU2001259511A AU5951101A AU2001259511A1 AU 2001259511 A1 AU2001259511 A1 AU 2001259511A1 AU 2001259511 A AU2001259511 A AU 2001259511A AU 5951101 A AU5951101 A AU 5951101A AU 2001259511 A1 AU2001259511 A1 AU 2001259511A1
- Authority
- AU
- Australia
- Prior art keywords
- infectives
- novel anti
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000002924 anti-infective effect Effects 0.000 title 1
- 229960005475 antiinfective agent Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20194500P | 2000-05-05 | 2000-05-05 | |
| US60201945 | 2000-05-05 | ||
| PCT/US2001/014525 WO2001085720A1 (en) | 2000-05-05 | 2001-05-04 | Novel anti-infectives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001259511A1 true AU2001259511A1 (en) | 2001-11-20 |
Family
ID=22747931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001259511A Abandoned AU2001259511A1 (en) | 2000-05-05 | 2001-05-04 | Novel anti-infectives |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US6713502B2 (en) |
| EP (1) | EP1278743A4 (en) |
| JP (1) | JP2003532726A (en) |
| AU (1) | AU2001259511A1 (en) |
| WO (1) | WO2001085720A1 (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005511572A (en) * | 2001-11-02 | 2005-04-28 | グラクソ グループ リミテッド | Acyl dihydropyrrole derivatives as HCV inhibitors |
| GB0211418D0 (en) * | 2002-05-17 | 2002-06-26 | Glaxo Group Ltd | Compounds |
| US6930106B2 (en) * | 2002-07-01 | 2005-08-16 | Pharmacia & Upjohn Company | Inhibitors of HCV NS5B polymerase |
| GB0216985D0 (en) * | 2002-07-22 | 2002-08-28 | Glaxo Group Ltd | Compounds |
| WO2004037818A1 (en) * | 2002-10-24 | 2004-05-06 | Glaxo Group Limited | 1-acyl-pyrrolidine derivatives for the treatment of viral infections |
| AP2005003319A0 (en) | 2002-11-19 | 2005-06-30 | Achillion Pharmaceitucals Inc | Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| WO2004060889A1 (en) * | 2003-01-07 | 2004-07-22 | Glaxo Group Limited | 5-thiazole substituted 2-pyrrolidine-carboxylic acids |
| GB0304494D0 (en) * | 2003-02-27 | 2003-04-02 | Glaxo Group Ltd | Compounds |
| US7034051B2 (en) * | 2003-08-28 | 2006-04-25 | Adolor Corporation | Fused bicyclic carboxamide derivatives and methods of their use |
| PL1718608T3 (en) | 2004-02-20 | 2013-11-29 | Boehringer Ingelheim Int | Viral polymerase inhibitors |
| US7741347B2 (en) * | 2007-05-17 | 2010-06-22 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| KR20100123717A (en) * | 2008-02-12 | 2010-11-24 | 브리스톨-마이어스 스큅 컴퍼니 | Heterocyclic derivatives as hepatitis c virus inhibitors |
| MA32975B1 (en) * | 2008-12-22 | 2012-01-02 | Chemocentryx Inc | ANTAGONISTS OF C5AR |
| CN102812003B (en) | 2009-12-18 | 2015-01-21 | 欧洲筛选有限公司 | Pyrrolidine Or Thiazolidine Carboxylic Acid Derivatives, Pharmaceutical Composition And Methods For Use In Treating Metabolic Disordersas As Agonists Of G- Protein Coupled Receptor 43 (GPR43) |
| SI2585064T1 (en) | 2010-06-24 | 2017-08-31 | Chemocentryx, Inc. | C5ar antagonists |
| JP6854126B2 (en) | 2013-11-27 | 2021-04-07 | エピックス セラピューティクス | Compounds, pharmaceutical compositions, and methods for use in the treatment of inflammatory diseases |
| CN113121415B (en) | 2014-09-29 | 2025-09-02 | 凯莫森特里克斯股份有限公司 | Methods and intermediates for preparing C5aR antagonists |
| CN108601790A (en) | 2016-01-14 | 2018-09-28 | 凯莫森特里克斯股份有限公司 | The therapy of C3 glomerulopathies |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997005108A1 (en) * | 1995-07-26 | 1997-02-13 | Mitsubishi Chemical Corporation | Penicillaminamide derivatives |
| US6323180B1 (en) * | 1998-08-10 | 2001-11-27 | Boehringer Ingelheim (Canada) Ltd | Hepatitis C inhibitor tri-peptides |
-
2001
- 2001-05-04 US US10/275,426 patent/US6713502B2/en not_active Expired - Fee Related
- 2001-05-04 EP EP01933049A patent/EP1278743A4/en not_active Withdrawn
- 2001-05-04 JP JP2001582321A patent/JP2003532726A/en not_active Withdrawn
- 2001-05-04 AU AU2001259511A patent/AU2001259511A1/en not_active Abandoned
- 2001-05-04 WO PCT/US2001/014525 patent/WO2001085720A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1278743A1 (en) | 2003-01-29 |
| US6713502B2 (en) | 2004-03-30 |
| EP1278743A4 (en) | 2003-05-14 |
| US20040010030A1 (en) | 2004-01-15 |
| WO2001085720A1 (en) | 2001-11-15 |
| JP2003532726A (en) | 2003-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001261377A1 (en) | Novel anti-infectives | |
| AU2002365198A1 (en) | Novel anti-infectives | |
| AU2001262847A1 (en) | Language-understanding | |
| AU2001292739A1 (en) | 1-oxorapamycins | |
| AU2002211620A1 (en) | Autoanastomosis | |
| AU2001254546A1 (en) | Aminopiperidines | |
| AU2000267458A1 (en) | Hypercomputer | |
| AU2001239310A1 (en) | Decahydro-isoquinolines | |
| AU2001296577A1 (en) | Chlorophyllases | |
| AU2001258349A1 (en) | Bisacylguanidine | |
| AU2001279754A1 (en) | Indoloquinazolinones | |
| AU2001259511A1 (en) | Novel anti-infectives | |
| AU2002211128A1 (en) | Step-bike | |
| AU2001290931A1 (en) | Ski-snowboard | |
| AU2001281965A1 (en) | Novel 6-phenylphenanthridines | |
| AU2001285886A1 (en) | 2-guanidino-4-aryl-quinazoline | |
| AU2001293852A1 (en) | Sulfonylguanidine | |
| AU2001258924A1 (en) | Microsatellite-aflp | |
| AU2002226346A1 (en) | 2-aryl-5-trifluoromethylpyridines | |
| AU2001246864A1 (en) | Hypotensors | |
| AU2001291876A1 (en) | Triazolo-epothilones | |
| AU2002214354A1 (en) | Neck-phone | |
| AU2001226668A1 (en) | Crankshaft-starter-generator | |
| AU2001295713A1 (en) | Blast-processing | |
| AU2001262711A1 (en) | Cytoprotectors |